24.06 USD
-0.1 (-0.41%)
24.1 USD
+0.04 (+0.17%)
ChartMill assigns a Buy % Consensus number of 55% to MRNA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 41.54. This target is 72.64% above the current price.
MRNA was analyzed by 30 analysts. The buy percentage consensus is at 55. So analysts seem to be rather neutral about MRNA.
In the previous month the buy percentage consensus was at a similar level.
MRNA was analyzed by 30 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-21 | Leerink Partners | Maintains | Underperform -> Underperform |
| 2025-11-21 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-11-21 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-11-10 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-11-07 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-23 | UBS | Maintains | Buy -> Buy |
| 2025-10-23 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-10-23 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-10-20 | Needham | Reiterate | Hold -> Hold |
| 2025-10-10 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-22 | Leerink Partners | Maintains | Underperform -> Underperform |
| 2025-08-04 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-22 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-05-22 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-05-02 | UBS | Maintains | Buy -> Buy |
| 2025-05-02 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-05-02 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-02 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-04-09 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-03-21 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-03-13 | Citigroup | Initiate | Neutral |
| 2025-02-19 | UBS | Maintains | Buy -> Buy |
| 2025-02-18 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2025-02-18 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2025-02-11 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-01-29 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2025-01-28 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-01-27 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-01-15 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-01-08 | UBS | Maintains | Buy -> Buy |
MODERNA INC / MRNA FAQ
Can you provide the average price target for MODERNA INC stock?
30 analysts have analysed MRNA and the average price target is 41.54 USD. This implies a price increase of 72.64% is expected in the next year compared to the current price of 24.06.
What is the consensus rating for MODERNA INC (MRNA) stock?
The consensus rating for MODERNA INC (MRNA) is 55.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.